Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
CD40-Stimulated Dendritic Cells Boost Immunity, But Not Disease Resistance
April 11th, 2001
by N.R. Saltmarsh, staff medical writer - Using dendritic cells stimulated with the cytokine CD40 to vaccinate against tuberculosis enhances immune response to the disease, but does not prevent lung infection, researchers have found. Caroline Demangel and colleagues in Australia proposed that a vaccination strategy optimizing interleukin 12 (IL-12) production by antigen-presenting cells (APCs) could stimulate immunity to TB infection. "Since dendritic cells (DC) are the critical APC for activation of CD4+ and CD8+ T cells, we examined whether stimulation of Mycobacterium bovis bacillus Calmette-Guerin (BCG)-infected DC...
Source: Vaccine Weekly (2001-04-11)
|
